Navigation Links
Interleukin Genetics Announces Management and Board Appointments
Date:9/6/2007

Names Thomas Gerson as Chief Financial Officer and James Weaver as Chairman

WALTHAM, Mass., Sept. 6 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI) announced today that Thomas Gerson has been named Chief Financial Officer. The Interleukin Board also appointed James Weaver as Chairman of the Board of Directors. In addition, Nazneen Aziz has joined the company as Vice President, Research and Development.

"We are pleased to welcome Tom to Interleukin," said Thomas Curran, Interim Chief Executive Officer. "Tom's more than 25 years of financial and industry experience, as well as his leadership and strategy skills will help the company focus on our current business objectives. Also, Nazneen is an excellent addition to our research and development team. She will focus primarily on guiding the development of pharmacogenetic and nutrigenetic tests and matching preventive/therapeutic products for medical applications."

Interleukin also announced that current Director James Weaver has been appointed as Chairman of the Board. Mr. Curran will remain on the Board as a Director, and focus on his role as Interim Chief Executive Officer.

Mr. Curran concluded, "With the announcements today, we are confident that Interleukin has a very strong leadership team in place to make progress on our goals. Interleukin is continuing its search to complete this team with the best possible candidate for the role of permanent CEO."

Thomas Gerson has held various financial and leadership roles for more than 25 years. Most recently he was Chief Financial Officer and VP of Business Operations at HistoRx, Inc. Previously, he was Chief Financial Officer, Treasurer and Assistant Secretary at CGI Pharmaceuticals,
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Wisconsin court affirms damages in Innogenetics, Abbott patent case
2. Third Wave licenses Innogenetics tech to settle lawsuit
3. Symposium examines the effect of race on genetics and disease
4. Speaker announces business members of IT Task Force
5. Doyle announces technology tax credits for Berbee
6. Doyle announces new energy, global warming policies
7. Doyle announces $80M renewable energy strategy
8. GE announces first installation of Discovery VCT
9. UWM announces winners of RGI awards
10. Third Wave announces two senior management appointments
11. Mirus announces new method for making antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Miami, FL (PRWEB) June 17, 2013 As ... Action are committed to finding a cure all for acne, ... Month, the AARS (Acne and Rosacea Society) ... skin conditions, and helping to educate the public on treatment ... leading society by announcing their daily news updates via social ...
(Date:6/17/2013)... 17, 2013 /PRNewswire-iReach/ -- The latest research on stuttering ... to explore the neurophysiological nature of stuttering, its connection ... such as bullying and teasing. (Photo: ... their latest findings at the National Stuttering Association,s 2013 ... More than 75 speech professionals and researchers ...
(Date:6/17/2013)... The ALS Therapy Development Institute (ALS TDI) will hold ... event on July 19-21, 2013. The Tri-State Trek is a three-day, ... to Greenwich, CT with the mission to ... disease). (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO ) ... passes through 46 communities and includes 12 rest stops, ...
(Date:6/17/2013)... June 17, 2013 Yongye International, Inc. (NASDAQ: ... manufacturer, and distributor of crop nutrient products in ... announced today that its common stock will resume trading ... 2013 at 7:15 a.m. Eastern Time. As ... on Monday, March 18, 2013 following Yongye,s notification that ...
Breaking Biology Technology:Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions 2New Research On Stuttering Jul 2-3 At Arizona Symposium 2New Research On Stuttering Jul 2-3 At Arizona Symposium 3ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 2ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 2Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 4
... a new study conducted at the Pennington Biomedical Research Center, ... over the past fifty years is a significant contributor to ... intake cannot solely account for observed trends in weight gain ... The study, entitled "Trends Over 5 Decades in U.S. ...
... Rules-Based Medicine (RBM), a global leader in biomarker ... achieved a significant milestone in a companion diagnostic ... Roche clinical trial, the RBM DiscoveryMAP® platform, and ... was identified that has utility in prognosis of ...
... May 25, 2011 WaferGen Biosystems, Inc. (OTCBB:WGBS), ... today announced it has entered into definitive agreements ... Point Partners, LLC, Deerfield Management and Merlin Nexus, ... in a $30.4 million private placement financing of ...
Cached Biology Technology:Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic 2Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic 3Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Program With Roche 2WaferGen Announces $30 Million Financing 2WaferGen Announces $30 Million Financing 3WaferGen Announces $30 Million Financing 4
(Date:6/17/2013)... the topics under discussion during the E3 Forum, ... consecutive year, this will be a unique event ... members of Academy, Business, Educators, Entrepreneurs, Innovators, Policy-makers ... Martn Garijo (IBM South Europe), Chris Zegras (MIT), ... (Hovione), among others. E3 Forum - Education, Employment ...
(Date:6/16/2013)... sex workers in India reduce rates of syphilis, HIV ... Toronto study has found. , About two ... southern states of Andhra Pradesh, Karnataka, Maharashtra and Tamil ... U of T,s Dalla Lana School of Public Health ... (CGHR), examined the impact of prevention among female sex ...
(Date:6/15/2013)... in Europe to treat osteoporosis has now been shown ... in cancers that have become resistant to current targeted ... The findings, presented June 15, 2013, at the annual ... drug bazedoxifene packs a powerful one-two punch that not ... but also flags the estrogen receptor for destruction. , ...
Breaking Biology News(10 mins):'E3 Forum -- Education, Employment & Entrepreneurship on a Global context' 2HIV prevention among female sex workers in India reduces HIV and syphilis 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
... Institut de recherches cliniques de Montréal (IRCM) have ... determines susceptibility to candidiasis, a common and often ... immunodeficiency virus (HIV). These findings, revealed using a ... developed by the same research group, represents a ...
... at the University of York have made a huge leap ... research group in the Department of Biology has made a ... a type of biological warfare. , Bacteria like E. coli ... using protein antibiotics called colicins, which are potent toxins. ...
... has developed a small, relatively inexpensive "seeing machine" that ... like her, to access the Internet, view the face ... Recently the machine received positive feedback from 10 visually ... vision loss who tested it in a pilot clinical ...
Cached Biology News:Montreal researchers identify defects of immune cells 2MIT 'seeing machine' offers hope to blind 2MIT 'seeing machine' offers hope to blind 3MIT 'seeing machine' offers hope to blind 4
MOUSE ANTI HUMAN C-MYC aa171-188...
MOUSE ANTI SIMIAN VIRUS 5 Immunogen: Simian virus 5...
ANTI ALPHA FSH:B...
... Serum • Beagle serum is collected from ... year of age Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium ... Alsevers N-05: ACD N-07: ...
Biology Products: